Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
35,872,648
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
20,709,688
-
Shares change
-
+20,402,700
-
Total reported value, excl. options
-
$430,774,211
-
Value change
-
+$424,388,861
-
Number of buys
-
56
-
Price
-
$20.80
Institutional Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) as of Q3 2024
As of 30 Sep 2024 BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) had 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,709,688 shares of stock of the company.
Largest 10 holders included AH Capital Management, L.L.C., Sofinnova Investments, Inc., RA CAPITAL MANAGEMENT, L.P., Cormorant Asset Management, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Sands Capital Ventures, LLC, ALLIANCEBERNSTEIN L.P., RTW INVESTMENTS, LP, and Pivotal bioVenture Partners Investment Advisor LLC.
This table shows 58 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.